Blog Posts

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS

Dec 28, 2023

Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With Read More

DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART I: BIG PHARMA’S EGREGIOUS PRICING PRACTICES

Dec 26, 2023

Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch Read More

DOSE OF REALITY: EXPERT WITNESS HIGHLIGHTS BIG PHARMA’S EGREGIOUS PRICING OF NEW WEIGHT LOSS DRUGS

Dec 19, 2023

Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight Read More

DOSE OF REALITY: BIG PHARMA’S INNOVATION TAP DANCE HAS INDUSTRY TRIPPING OVER ITS OWN RHETORIC

Dec 12, 2023

Big Pharma Continues Pushing Myth That Solutions to Lower Rx Prices Will Read More

BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST EIGHT BRAND NAME DRUGS COST U.S. $1.2 BILLION IN 2022

Dec 11, 2023

New Analysis Showcases How Big Pharma Raises Prices on Blockbuster Products Read More

DOSE OF REALITY: VOTERS WANT CANDIDATES TALKING ABOUT DRUG PRICES AND FOCUSED ON HOLDING BIG PHARMA ACCOUNTABLE

Dec 6, 2023

KFF Survey Finds Americans Want White House Contenders Talking Rx Prices, Read More

BIG PHARMA WATCH: PHARMA PATENTS INVALIDATED MORE THAN ANY OTHER INDUSTRY FOR MISREPRESENTED OR OMITTED INFORMATION

Nov 17, 2023

Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY, GLAXOSMITHKLINE AND ASTRAZENECA

Nov 14, 2023

Another Blockbuster Quarter for Profits as Big Pharma Maintains Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND AMGEN

Nov 3, 2023

Another Series of Strong Earnings Reports For Brand Name Giants Fueled by Read More